Skip to main content

Table 2 Statistical Analysis of Therapeutic Response and Prognosis in the Two Groups

From: Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs

   Experimental group (cases) Control group (cases) p value
Chemotherapy response CR 2 1 <0.05
  PR 11 5  
  SD 2 10  
Surgical margin Negative 13 6 <0.01
  Positive 2 10  
Progression free survival Yes 10 4 <0.05
  No 5 12